4SC AG

The European Medicines Agency has begun reviewing a new batch of drugs for potential pan-EU marketing approval, including resmetirom, Madrigal Pharmaceuticals ’ THR-β agonist, which is awaiting a dec

The executives we surveyed on the clinical trial landscape identified several sweeping trends that are expected to drive change over the coming year. As in so many spheres, data, digital technology an

The recent concerns in the US over the risk-benefit balance for phosphatidylinositol 3-kinase (PI3K) inhibitors have cast a new shadow over the pharmaceutical business of diversified Japanese firm Ya

Johnson & Johnson group worldwide chairman Sandra Peterson is leaving the business, effective Oct. 1, after more than five years with the company. Peterson, who reports to CEO and chair of the bo